数字农科院2.0

Piglets with maternally derived antibodies from sows immunized with rAdV-SFV-E2 were completely protected against lethal CSFV challenge

文献类型： 外文期刊

作者： Xia, Shui-Li;Du, Mingliang;Lei, Jian-Lin;Liu, Yan;Wang, Yimin;Ji, Shengwei;Xiang, Guang-Tao;Li, Lian-Feng;Cong, Xin;Luo, Yuzi;Shao, Lina;Qiu, Hua-Ji;Sun, Yuan

作者机构：

关键词： Classical swine fever;Marker vaccine;Maternally derived antibodies;Passive protection

期刊名称： VETERINARY MICROBIOLOGY

ISSN：

年卷期：

页码：

收录情况： SCI

摘要： Classical swine fever (CSF) is an economically important infectious disease of pigs caused by Classical swine fever virus (CSFV). To facilitate the eradication of CSF in endemic areas, a marker vaccine enabling differentiation of infected from vaccinated animals (DIVA) is urgently needed. Previously, we have demonstrated that the DIVA vaccine rAdV-SFV-E2, an adenovirus-vectored Semliki Forest virus replicon expressing the E2 glycoprotein of CSFV, induces complete protection from lethal CSFV challenge. The aim of this study was to investigate whether maternally derived antibodies (MDAs) from sows immunized with rAdV-SFV-E2 can effectively protect piglets against lethal CSFV challenge. Three groups of five-week-old piglets (n=4), with or without MDAs, were challenged with the highly virulent CSFV Shimen strain. Clinical signs, CSFV-specific antibodies, viremia and pathological and histopathological changes were monitored. The results showed that the piglets with MDAs from the sow immunized with rAdV-SFV-E2 were protected clinically, virologically and pathologically, while the piglets with undetectable MDAs from the rAdV-SFV-E2-immunized sow were partially protected (2/4 survival), in contrast with the piglets from the non-vaccinated sow, which displayed CSF-typical clinical signs, viremia, deaths (4/4) and pathological/histopathological lesions. These results indicate that MDAs from the sow immunized with rAdV-SFV-E2 are able to confer full passive immunity to newborn piglets. (C) 2016 Elsevier B.V. All rights reserved.

分类号： S8

  • 相关文献

[1]Efficacy of the marker vaccine rAdV-SFV-E2 against classical swine fever in the presence of maternally derived antibodies to rAdV-SFV-E2 or C-strain. Xia, Shui-Li,Xiang, Guang-Tao,Lei, Jian-Lin,Du, Mingliang,Wang, Yimin,Zhou, Mo,Liu, Yan,Ji, Shengwei,Wang, Ya-Lin,Luo, Yuzi,Sun, Yuan,Qiu, Hua-Ji.

[2]Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type. Sandbulte, Matthew R.,Roth, James A.,Kitikoon, Pravina,Vincent, Amy L.,Gauger, Phillip C.,Chen, Hongjun,Perez, Daniel R.,Sandbulte, Matthew R.,Kitikoon, Pravina,Chen, Hongjun,Perez, Daniel R..

[3]Comprehensive evaluation of the adenovirus/alphavirus-replicon chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever. Qiu, Hua-Ji. 2013

[4]Enhancement of the immunogenicity of an alphavirus replicon-based DNA vaccine against classical swine fever by electroporation and coinjection with a plasmid expressing porcine interleukin 2. Tian, Da-Yong,Sun, Yuan,Meng, Qi-Lin,Wang, Nan,Han, Wen,Li, Su,Li, Yong-Feng,Li, Dan,Ling, Li-Jun,Liao, Ya-Jin,Qiu, Hua-Ji,Wai, Sing Fai,Lee, Fuk Ki,Suen, Kar Man.

[5]Classical swine fever in China: A minireview. Luo, Yuzi,Li, Su,Sun, Yuan,Qiu, Hua-Ji.

[6]Safety and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the E2 protein of classical swine fever virus in pigs. Lei, Jian-Lin,Xia, Shui-Li,Wang, Yimin,Du, Mingliang,Xiang, Guang-Tao,Cong, Xin,Luo, Yuzi,Li, Lian-Feng,Zhang, Lingkai,Yu, Jiahui,Qiu, Hua-Ji,Sun, Yuan,Lei, Jian-Lin,Hu, Yonghao.

[7]A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever. Sun, Yuan,Li, Hong-Yu,Tian, Da-Yong,Han, Qiu-Ying,Zhang, Xin,Li, Na,Qiu, Hua-Ji. 2011

[8]H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens. Li, Chengjun,Ping, Jihui,Jing, Bo,Deng, Guohua,Jiang, Yongping,Li, Yanbing,Tian, Guobin,Yu, Kangzhen,Bu, Zhigao,Chen, Hualan. 2008

[9]A live, attenuated pseudorabies virus strain JS-2012 deleted for gE/gI protects against both classical and emerging strains. Tong, Wu,Li, Guoxin,Liang, Chao,Liu, Fei,Tian, Qing,Cao, Yanyun,Li, Lin,Zheng, Xuchen,Zheng, Hao,Tong, Guangzhi,Tong, Wu,Li, Guoxin,Tong, Guangzhi.

[10]A novel dendrimeric peptide induces high level neutralizing antibodies against classical swine fever virus in rabbits. Li, Guo-Xin,Zhou, Yan-Jun,Yu, Hai,Li, Ling,Wang, Ya-Xin,Tong, Wu,Hou, Jun-Wei,Xu, Yan-Zhao,Zhu, Jian-Ping,Xu, Ao-Tian,Tong, Guang-Zhi.

[11]Recombination and expression of classical swine fever virus (CSFV) structural protein E2 gene in Chlamydomonas reinhardtii chroloplasts. He, Dong-Mei,Qian, Kai-Xian,Shen, Gui-Fang,Zhang, Zhi-Fang,Li, Yi-Nue,Su, Zhong-Liang,Shao, Hong-Bo.

[12]Stable expression of foreign gene in nonessential region of nonstructural protein 2 (nsp2) of porcine reproductive and respiratory syndrome virus: Applications for marker vaccine design. Xu, Yan-Zhao,Zhou, Yan-Jun,Zhang, Shan-Rui,Jiang, Yi-Feng,Tong, Wu,Yu, Hai,Tong, Guang-Zhi.

[13]Progress of reverse genetics technique in influenza virus. Liu Da-Fei,Liu Chun-Guo,Liu Ming,Liu Da-Cheng. 2008

[14]A high-temperature passaging attenuated Pseudorabies vaccine protects piglets completely. against emerging PRV variant. Liang, Chao,Zhou, En-min,Liang, Chao,Tong, Wu,Zheng, Hao,Liu, Fei,Wu, Jiqiang,Li, Guoxin,Tong, Guangzhi,Tong, Wu,Zheng, Hao,Li, Guoxin,Tong, Guangzhi.

[15]The rescue and evaluation of FLAG and HIS epitope-tagged Asia 1 type foot-and-mouth disease viruses. Yang, Bo,Yang, Fan,Zhang, Yan,Liu, Huanan,Jin, Ye,Cao, Weijun,Zhu, Zixiang,Zheng, Haixue,Yin, Hong.

作者其他论文 更多>>